المؤلفون: M. S. Bolhuis, O. W. Akkerman, M. G. G. Sturkenboom, J. F. M. van Boven, J-W. C. Alffenaar, J. Stevens

المساهمون: Microbes in Health and Disease (MHD), Groningen Research Institute for Asthma and COPD (GRIAC), Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 27(4), 335-337. International Union against Tubercul. and Lung Dis.

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Infectious Diseases, Diarylquinolines/therapeutic use, Antitubercular Agents/therapeutic use, Humans, Tuberculosis, Tuberculosis, Multidrug-Resistant/complications, Multidrug-Resistant/complications, Diabetes Complications/complications

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06cbaf522f4d0f2e5fb1f4f16f5a2f36
https://doi.org/10.5588/ijtld.22.0581